ReviewDiabetes care2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Thomas Danne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
154 papers cite itlatest 60 shown
this paperpooled ittrialcites it